Literature DB >> 6980259

Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates.

D J Volkman, A Ahmad, A S Fauci, D M Neville.   

Abstract

The feasibility of selectively eliminating human antigen-specific B cell responses by treating cells in vitro with antigen covalently linked to a cell toxin was examined. Tetanus toxoid (TT) was conjugated to the toxin ricin via a thioether linkage. Peripheral blood mononuclear cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells were stimulated with pokeweed mitogen to induce antibody production. TT-specific antibody production was completely abrogated by preincubation with TT-ricin but not by TT alone or a mixture of TT and ricin. In contrast, polyclonal immunoglobulin production was not diminished by TT-ricin. This selective abrogation was also seen when B cells alone were preincubated with TT-ricin and a source of T cell help was later provided. T cell blastogenic responses to TT remained intact after TT-ricin exposure. Thus, antigen-toxin conjugates are capable of selectively eliminating specific antibody-producing B cell clones, while leaving intact the remainder of the B cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980259      PMCID: PMC2186768          DOI: 10.1084/jem.156.2.634

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.

Authors:  R J Youle; D M Neville
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

3.  The mannose 6-phosphate receptor of Chinese Hamster ovary cells. Isolation of mutants with altered receptors.

Authors:  A R Robbins; R Myerowitz; R J Youle; G J Murray; D M Neville
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

4.  Immunoregulation in autoimmunity.

Authors:  A S Fauci
Journal:  J Allergy Clin Immunol       Date:  1980-07       Impact factor: 10.793

5.  Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

Authors:  K A Krolick; C Villemez; P Isakson; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin.

Authors:  R J Youle; G J Murray; D M Neville
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

7.  Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation.

Authors:  D J Volkman; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Artificial hybrid protein containing a toxic protein fragment and a cell membrane receptor-binding moiety in a disulfide conjugate. I. Synthesis of diphtheria toxin fragment A-S-S-human placental lactogen with methyl-5-bromovalerimidate.

Authors:  T M Chang; D M Neville
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

9.  Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.

Authors:  R J Youle; D M Neville
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements.

Authors:  H C Lane; D J Volkman; G Whalen; A S Fauci
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  4 in total

1.  Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Authors:  L G Durrant; V S Byers; P J Scannon; R Rodvien; K Grant; R A Robins; R A Marksman; R W Baldwin
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 2.  Treatment of B-cell lymphoma using peptides. A novel concept.

Authors:  K S Lam
Journal:  West J Med       Date:  1993-05

Review 3.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

4.  Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.

Authors:  Diana Klose; Ute Saunders; Stefan Barth; Rainer Fischer; Annett Marita Jacobi; Thomas Nachreiner
Journal:  BMC Biotechnol       Date:  2016-02-17       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.